Free Submission Public Relations &
Deutsch English

Terumo Corporation - SWOT, Strategy and Corporate Finance Report

Terumo Corporation - SWOT, Strategy and Corporate Finance Report - new company profile report published

Print article Print article
2013-01-24 00:36:55 - Terumo Corporation - SWOT, Strategy and Corporate Finance Report - a new company profile report on

Terumo Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company´s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.


- Detailed information on Terumo Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Terumo Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Terumo Corporation including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Terumo Corporation
- Intelligence on Terumo Corporationnv´s mergers



and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Terumo Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends


Terumo is a medical technology company engaged in the manufacture and sale of a range of medical products and equipment, including pharmaceuticals. The company operates in Asia, Europe, North America, and South America. It is headquartered in Tokyo, Japan and employed 14,761 people as of March 31, 2011. The company recorded revenues of JPY328,214 million ($3,840.1 million*) during the financial year ended March 2011 (FY2011), an increase of 3.9% over FY2010. The operating profit of the company was JPY62,607 million ($732.5 million*) in FY2011, a decrease of 1.1% over FY2010. The net profit was JPY32,339 million ($378.4 million*) in FY2011, a decrease of 20.6% over FY2010. *Calculated using the constant conversion rate of JPY1 = $0.0117 for the financial year ended March 31, 2011.
Reasons to Purchase:

- Gain understanding of Terumo Corporation and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Terumo Corporation as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers´ businesses better
- Stay up to date on Terumo Corporation´s business structure, strategy and prospects

Click for report details: ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Company Profile Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact